Celularity Inc.
NASDAQ:CELUBiotechnology
+$1.22 today
- Market cap
- $52.97M
- Beta
- 0.54
- P/E (TTM)
- -0.6
- EPS (TTM)
- -$3.58
Volume 0.00M
Average 0.13M
CELU Other Non-current Liabilities
Long-term obligations not reported separately, such as lease or pension liabilities.
Celularity Inc.NASDAQ: CELU
Other Non-current Liabilities · Q4 FY2025 · quarter ended Dec 2025
Other non-current liabilities rises 604.5% from a year ago
Other non-current liabilities stood at $34.92M at the end of Q4 FY2025, up 604.5% from a year earlier and up 570.8% from the prior quarter. Over 3 fiscal years it compounded at -31.8% a year.
Context
- Other non-current liabilities amounted to 32.5% of total assets at the end of Q4 FY2025, up 28.8 pp from a year earlier.
- Other non-current liabilities increased in 1 of the last 3 fiscal years.
What to watch
Whether other non-current liabilities keeps rising in the next quarterly balance sheet after a +604.5% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Non-current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 34.92M USD
- Year-over-year change
- +604.5%
- 4-year CAGR
- -39.4%
| Period | Period end | Other Non-current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 34.92M | +604.5% |
| FY2024 | 2024-12-31 | 4.96M | -20.8% |
| FY2023 | 2023-12-31 | 6.26M | -94.3% |
| FY2022 | 2022-12-31 | 109.86M | -57.5% |
| FY2021 | 2021-12-31 | 258.52M | — |
Other Non-current Liabilities vs competitors
How CELU compares with its peers on the latest reported figures
- CELU's Dec 2025 other non-current liabilities of $34.92M is the highest of the 4 companies compared; the peer median is $327K.
- Its year-over-year change of +604.5% is the highest of 3, against a peer median of +41.0%.
- Other non-current liabilities amounts to 32.5% of total assets for CELU, versus a peer median of 2.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Dec 2025 | $34.92M | +604.5% | -31.8% | 32.5% | |
| Mar 2026 | $401K | -0.7% | +115.6% | 2.1% | |
| Mar 2026 | $327K | +82.7% | — | 2.0% | |
| Jun 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding CELU) | $327K | +41.0% | +115.6% | 2.0% | |
Competitors are the stored peer set for CELU. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 37.24M | 13.97M | 227K | 738K | 6.18M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 5.23M | 6.97M | 12.12M | 13.56M | 4.65M |
| Inventory | 9.55M | 5.31M | 5.75M | 5.41M | 571K |
| Other Current Assets | 2K | 1.05M | 329K | 857K | 222K |
| Total Current Assets | 59.1M | 33.5M | 19.79M | 20.56M | 12.32M |
| Property, Plant & Equipment (Net) | 90.63M | 88.72M | 78.82M | 72.43M | 66.52M |
| Goodwill | 123.3M | 119.69M | 7.35M | 7.35M | 7.35M |
| Intangible Assets | 123.19M | 120.99M | 11M | 9.25M | 7.76M |
| Long-term Investments | 14.84M | 14.84M | 9.94M | 10.24M | 0 |
| Tax Assets | 0 | 9K | (9.94M) | 0 | 0 |
| Other Non-current Assets | 3.08M | 23.32M | 26.93M | 12.86M | 13.39M |
| Total Non-current Assets | 355.03M | 367.56M | 124.1M | 112.12M | 95.01M |
| Total Assets | 414.13M | 401.07M | 143.89M | 132.68M | 107.33M |
| Account Payables | 9.32M | 5.81M | 14.14M | 23.3M | 26.42M |
| Short-term Debt | 3.05M | 37.6M | 39.24M | 6.36M | 14M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 2.2M | 2.27M | 2.83M | 3.53M | 5.26M |
| Other Current Liabilities | 7.84M | 13.83M | 8.07M | 1.61M | 6.93M |
| Total Current Liabilities | 26.23M | 62.09M | 67.3M | 53.68M | 80.76M |
| Long-term Debt | 0 | 0 | 0 | 35.93M | 0 |
| Deferred Tax Liabilities | 10K | 9K | 9K | 9K | 12K |
| Deferred Revenue (Non-current) | 1.87M | 2.22M | 3.19M | 2.72M | 2.8M |
| Other Non-current Liabilities | 258.52M | 109.86M | 6.26M | 4.96M | 34.92M |
| Total Non-current Liabilities | 288.48M | 140.08M | 35.63M | 70.17M | 64.63M |
| Total Liabilities | 314.71M | 202.17M | 102.93M | 123.85M | 145.39M |
| Common Stock | 12K | 15K | 19K | 2K | 3K |
| Retained Earnings | (663.68M) | (645.5M) | (841.79M) | (899.68M) | (991.48M) |
| Accumulated OCI | 0 | 9K | 0 | (5K) | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 99.42M | 198.9M | 40.96M | 8.84M | (38.06M) |
| Total Debt | 31.14M | 65.59M | 65.42M | 68.84M | 40.9M |
| Net Debt | (6.1M) | 51.62M | 65.19M | 68.1M | 34.73M |
Celularity Inc.
NASDAQ:CELU
Intrinsic Alpha fair value
Locked
Current Price
$1.83
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.